美股
Lead report
Moderna Evaluates German Production Facilities as BioNTech Shuts Down Plants: mRNA Vaccine Industry in Flux
Moderna is reportedly assessing the acquisition of production facilities in Germany, while BioNTech plans to close some plants. This shift reflects post-pandemic capacity rebalancing in the mRNA vaccine sector, offering insights for U.S. biotech investment strategies.
